BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34538014)

  • 1. Validation and public health modelling of risk prediction models for kidney cancer using the UK Biobank.
    Harrison H; Pennells L; Wood A; Rossi SH; Stewart GD; Griffin SJ; Usher-Smith JA
    BJU Int; 2022 Apr; 129(4):498-511. PubMed ID: 34538014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of risk prediction models for incident colorectal cancer using UK Biobank.
    Usher-Smith JA; Harshfield A; Saunders CL; Sharp SJ; Emery J; Walter FM; Muir K; Griffin SJ
    Br J Cancer; 2018 Mar; 118(5):750-759. PubMed ID: 29381683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the Effectiveness of Kidney Cancer Screening Within Lung Cancer Screening Programmes: A Validation in UK Biobank.
    Harrison H; Wood A; Pennells L; Rossi SH; Callister M; Cartledge J; Stewart GD; Usher-Smith JA
    Eur Urol Oncol; 2023 Jun; 6(3):351-353. PubMed ID: 37003861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Validation of Risk Prediction Models Incorporating Common Genetic Variants for Incident Colorectal Cancer Using UK Biobank.
    Saunders CL; Kilian B; Thompson DJ; McGeoch LJ; Griffin SJ; Antoniou AC; Emery JD; Walter FM; Dennis J; Yang X; Usher-Smith JA
    Cancer Prev Res (Phila); 2020 Jun; 13(6):509-520. PubMed ID: 32071122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
    Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
    Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-cancer risk stratification based on national health data: a retrospective modelling and validation study.
    Jung AW; Holm PC; Gaurav K; Hjaltelin JX; Placido D; Mortensen LH; Birney E; Brunak SR; Gerstung M
    Lancet Digit Health; 2024 Jun; 6(6):e396-e406. PubMed ID: 38789140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort study.
    Briggs SEW; Law P; East JE; Wordsworth S; Dunlop M; Houlston R; Hippisley-Cox J; Tomlinson I
    BMJ; 2022 Nov; 379():e071707. PubMed ID: 36351667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
    Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
    EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Prediction Models for Kidney Cancer: A Systematic Review.
    Harrison H; Thompson RE; Lin Z; Rossi SH; Stewart GD; Griffin SJ; Usher-Smith JA
    Eur Urol Focus; 2021 Nov; 7(6):1380-1390. PubMed ID: 32680829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies.
    Smith T; Muller DC; Moons KGM; Cross AJ; Johansson M; Ferrari P; Fagherazzi G; Peeters PHM; Severi G; Hüsing A; Kaaks R; Tjonneland A; Olsen A; Overvad K; Bonet C; Rodriguez-Barranco M; Huerta JM; Barricarte Gurrea A; Bradbury KE; Trichopoulou A; Bamia C; Orfanos P; Palli D; Pala V; Vineis P; Bueno-de-Mesquita B; Ohlsson B; Harlid S; Van Guelpen B; Skeie G; Weiderpass E; Jenab M; Murphy N; Riboli E; Gunter MJ; Aleksandrova KJ; Tzoulaki I
    Gut; 2019 Apr; 68(4):672-683. PubMed ID: 29615487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction of a Risk Prediction Model for Lung Cancer Based on Lifestyle Behaviors in the UK Biobank Large-Scale Population Cohort].
    Chen R; Wang J; Wang S; Tang S; Suo C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):892-898. PubMed ID: 37866943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of models for predicting risk of colorectal cancer using the China Kadoorie Biobank.
    Abhari RE; Thomson B; Yang L; Millwood I; Guo Y; Yang X; Lv J; Avery D; Pei P; Wen P; Yu C; Chen Y; Chen J; Li L; Chen Z; Kartsonaki C
    BMC Med; 2022 Sep; 20(1):302. PubMed ID: 36071519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Suicidal Behaviors in the Middle-aged Population: Machine Learning Analyses of UK Biobank.
    Wang J; Qiu J; Zhu T; Zeng Y; Yang H; Shang Y; Yin J; Sun Y; Qu Y; Valdimarsdóttir UA; Song H
    JMIR Public Health Surveill; 2023 Feb; 9():e43419. PubMed ID: 36805366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants.
    Alaa AM; Bolton T; Di Angelantonio E; Rudd JHF; van der Schaar M
    PLoS One; 2019; 14(5):e0213653. PubMed ID: 31091238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
    Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
    Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank.
    Parsons RE; Liu X; Collister JA; Clifton DA; Cairns BJ; Clifton L
    Heart; 2023 Oct; 109(22):1690-1697. PubMed ID: 37423742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancer® (Renal) prediction model.
    Collins GS; Altman DG
    Cancer Epidemiol; 2013 Apr; 37(2):115-20. PubMed ID: 23280341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering Clinical Risk Factors and Predicting Severe COVID-19 Cases Using UK Biobank Data: Machine Learning Approach.
    Wong KC; Xiang Y; Yin L; So HC
    JMIR Public Health Surveill; 2021 Sep; 7(9):e29544. PubMed ID: 34591027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
    Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
    PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.